Business / Finance

RSS

Instratek announces record revenue growth for 10th straight year and release of ToeTac implant

Instratek, a privately held medical device company focused on minimally invasive endoscopic surgery and extremity implants, announces record revenue growth for the 10th straight year. The company recorded solid year over year revenue growth of its extremity endoscopy business and extremity implants, including the recently released nitinol fixation staple, STAPiX.

12 Dec 2015

Ajinomoto Althea expands biological drug product manufacturing operations

Ajinomoto Althea, Inc., a leading provider of biopharmaceutical contract development and manufacturing services, recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs).

10 Dec 2015

Streamline Health signs new reseller agreement to provide Looking Glass CDI and Coding solutions to himagine solutions

Streamline Health Solutions, Inc., a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced a new reseller agreement to provide its Looking Glass CDI and Coding solutions to himagine solutions, inc.

9 Dec 2015

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

Roche today announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc., a privately-held company headquartered in Wilmington, Massachusetts, US.

8 Dec 2015

Kewaunee Scientific's sales increase 2.6% to $31 million in second quarter 2015

Kewaunee Scientific Corporation today reported results for its second quarter ended October 31, 2015.

8 Dec 2015

BioLight announces first sale of IOPtiMate system in Portugal

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the first sale of the IOPtiMate system to a medical center located in Portugal.

8 Dec 2015

Flex acquires Farm Design

Flex today announced that it has acquired Farm Design, a full-service, ISO 13485-certified and FDA-compliant product development company with more than 40 years of experience providing complete development and design services for medical device and diagnostic companies.

8 Dec 2015

One Medical Group raises $65 million in growth capital to support accelerated market expansion

One Medical Group, the national leader in technology-enabled primary care, today announced that it has raised $65 million of growth capital to support accelerated market expansion. The round was led by J.P. Morgan Asset Management on behalf of PEG Digital Growth Fund II L.P. and AARP Innovation Fund L.P. Current and new institutional and individual investors also participated.

8 Dec 2015

OncoSec reports net loss of $7.0 million for first quarter of fiscal 2016

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the first quarter of fiscal year ended July 31, 2016.

8 Dec 2015

BioAtla, Pfizer sign license and option agreement for new class of antibody therapeutics

BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it has entered into a license and option agreement with Pfizer Inc. to advance the development and commercialization of a new class of antibody therapeutics based on BioAtla's CAB platform and utilizing Pfizer's proprietary antibody drug conjugate (ADC) payloads.

8 Dec 2015

Comfort Medical acquires Medical Direct Club

Comfort Medical, LLC today announced its acquisition of Medical Direct Club, LLC, the third largest direct-to-consumer supplier of urological catheters and supplies in the U.S.

7 Dec 2015

Merus reports revenues of $49.0 million for fiscal 2015

Merus Labs International Inc. is pleased to report its financial results for fiscal year ending September 30, 2015.

7 Dec 2015

Excellence in graduate student research, third annual Kaluza prizes

Beckman Coulter collaborated with the American Society for Cell Biology to sponsor the Third Annual ASCB Kaluza Prizes for academic excellence.

From Beckman Coulter Life Sciences - Flow Cytometry 7 Dec 2015

Memorandum of understanding signed between Cell Therapy Catapult and Kanagawa Prefecture

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the signing of a memorandum of understanding with the Kanagawa Prefecture of Japan.

30 Nov 2015

Human Longevity announces acquisition of Cypher Genomics

Human Longevity, Inc., the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.

30 Nov 2015

SuperCom awarded $8 million in new contracts

SuperCom Ltd., a leading provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, today announced that it has been awarded new contracts, totaling approximately $8 million. The Company expects to deliver and recognize the full value of the orders during the first half of 2016.

30 Nov 2015

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.

30 Nov 2015

Mallinckrodt sells CMDS business to Guerbet for $270 million

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.

28 Nov 2015

Lannett acquires Kremers Urban Pharmaceuticals from UCB for $1.23 billion

Lannett Company, Inc. today announced that it has completed the acquisition of Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A.

27 Nov 2015

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

27 Nov 2015